The history of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in sales , its intellectual property lapse created a flood of knock-off medications, significantly impacting its dominance. While specific pharmaceutical companies may try to capitalize on similar cond